Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis

NCT04966559 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Pancreatitis, Acute

Interventions

DRUG: Placebo treatment
DRUG: Naldemedine 0.2 MG Oral Tablet

Sponsor

Asbjørn Mohr Drewes

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]